|
Protocol no. |
Title |
Status |
|
Protocol
210* |
Safety, acceptability, and preliminary effectiveness of Carraguard®
(PC-515) in preventing HIV/STI transmission |
Completed |
|
Protocol
270* |
Safety and acceptability of Carraguard®
among
HIV-negative couples in Thailand |
Completed |
|
Protocol
271* |
Safety, acceptability, and preliminary effectiveness of PC-515 for
vaginal use as a possible microbicide |
Completed |
|
Protocol
297* |
Safety and acceptability of Carraguard®
in HIV-positive
women and men |
Completed |
|
Protocol
300* |
Safety and efficacy of a contraceptive vaginal ring delivering
Nestorone®
and ethinyl estradiol |
Recruiting |
|
Protocol
316* |
A randomized, controlled, cross-over trial of safety of vaginal use
of Carraguard®
by HIV-infected women |
Completed |
|
Protocol
322* |
Efficacy study of the vaginal gel Carraguard®
to prevent
HIV transmission |
Ongoing |
|
Protocol
323* |
Effects of hormonal contraceptives on liver proteins and coagulation
factors |
Completed |
|
Protocol
395 |
A substudy to determine the efficacy and safety of the vaginal
microbicide Carraguard®, as an inhibitor of human papillomavirus (HPV)
infection |
Ongoing |
*
Information on this protocol is located offsite on
ClinicalTrials.gov, which
provides patients, family members, and members of the public easy and free
access to information on clinical studies for a wide range of diseases and
conditions.
